NEW YORK, Sept. 23 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:
Sanofi-Aventis: PharmaVitae Profile
http://www.reportlinker.com/p0201760/Sanofi-Aventis-PharmaVitae-Profile.html
Introduction
This analysis examines the historical and forecast performance
for Sanofi-Aventis in the pharmaceutical sector. The profile
encompasses global company strategy, portfolio and pipeline
analysis and assessment of financial per
ABOUT DATAMONITOR HEALTHCARE 2
About the PharmaVitae team 2
Chapter 1 About this profile 3
PharmaVitae Explorer database 3
Chapter structure 3
Executive summary 3
Quarterly update 3
Company introduction 3
Company sales 4
Company financials 4
Key products 4
Data sourcing 4
Sales data 4
Analyst consensus 4
Chapter 2 Executive summary 5
Key findings 5
Prescription pharmaceutical sales and growth rate performance,
2003-15 6
Financial performance, 2003-15 7
Sanofi-Aventis: PharmaVitae forecasts at a glance 8
Strategic insight 9
Diversification is priority for new CEO 9
M&A a key tool to achieve diversification targets 9
Sanofi Pasteur is central to diversified business model 11
Increasing RoW presence is at heart of diversification strategy
12
Parallel diversification occurring across Big Pharma peer set
12
Diversification will struggle to address near-term impact of
generic exposure 13
SWOT analysis 14
Strengths 14
Weaknesses 16
Opportunities 16
Threats 18
Table of Contents 20
Table of figures 2
‘/>”/>
